DH
Therapeutic Areas
Lifecore Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Sterile Injectable CDMO Services | Various (Client Drugs/Biologics/Devices) | Pre-clinical to Commercial |
| Sodium Hyaluronate (GMP API/Excipient) | Ophthalmology, Orthopedics, Dermatology | Commercial |
| Sodium Hyaluronate (Research-Use) | Pre-clinical Research | Research |
| Methacrylated NaHy / Custom Modifications | Hydrogels, Advanced Drug Delivery | Research to Commercial |
Leadership Team at Lifecore Biomedical
PJ
Paul Josephs
President & CEO
RD
Ryan D. Lake, CPA
Chief Financial Officer
TS
Tom Salus
Chief Legal and Administration Officer
JK
Jackie Klecker
Executive Vice President, Quality and Development Services
TG
Thomas Guldager
Sr. Vice President, Operations
DO
Dr. Otto Sartorius
Founder
MG
Marc Gleeson
CEO at Azura Ophthalmics Ltd (Customer Reference)